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favorable chiral environment. Achiral alkylamino acid spacers 3n
(n ) 1-5) and arylamino acid spacers 4q (q ) ortho-, meta-, para-)
were inserted between the biotin anchor and the amino-diphosphine
moieties 1 and 2 to afford ligands Biot-3n-1 and Biot-3n-2 as
well as Biot-4q-1 and Biot-4q-2 (Scheme 1).11
Using avidin as the host protein, introduction of a glycine spacer
has a beneficial effect both on the activity and on the selectivity of
catalysts [Rh(COD)(Biot-31-1)]+ and [Rh(COD)(Biot-31-2)]+
(60% ee (S) and 66% ee (S), respectively, entries 7 and 8). In
streptavidin, the sense of enantioselection for catalysts [Rh(COD)-
(Biot-31-1)]+ and [Rh(COD)(Biot-31-2)]+ is inverted as compared
to the catalysts devoid of spacer (24% ee (S) and 42% ee (R),
respectively, entries 9 and 10). The best result for avidin as the
host protein is obtained with [Rh(COD)(Biot-32-1)]+ (69% ee (S),
Scheme 1
Table 1. Enantioselective Hydrogenation of the Acetamidoacrylic
Acid Using Biotinylated Complexes in (Strept)avidina
entry ligand host protein buffer ee (%)
1 Biot-1 avidin phosphate 37 (S)b
2 Biot-2 avidin MOPS 0c
3 Biot-1 neutravidin phosphate 7 (S)d
4 Biot-2 neutravidin MOPS 10 (S)d
5 Biot-1 streptavidin acetate 92 (R)
6 Biot-2 streptavidin acetate 20 (S)e
7 Biot-31-1 avidin MOPS 60 (S)
8 Biot-31-2 avidin MOPS 66 (S)
9 Biot-31-1 streptavidin acetate 24 (S)
10 Biot-31-2 streptavidin acetate 42 (R)
11 Biot-32-1 avidin MOPS 69 (S)
12 Biot-4ortho-1 streptavidin acetate 92 (R)
13 Biot-1 strept. S122G acetate 96 (R)
14 Biot-4ortho-1 strept. S122G acetate 94 (R)
a Unless otherwise stated, conversions (conv.) were quantitative after
15 h. b 90% conv. c 94% conv. d 87% conv. e 55% conv. The ee and
conversion were determined by GC (after 15 h at room temperature, 5 atm
H2, buffer).11 Hydrogenation with all biotinylated catalysts in the absence
of a host protein produced essentially racemic material (ee < 8%,
quantitative).
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Enantioselective catalysis is one of the most efficient ways to 
synthesize high-added-value enantiomerically pure organic com-
pounds.1 As the subtle details which govern enantioselection cannot 
be reliably predicted or computed, catalysis relies more and more 
on a combinatorial approach.2 Biocatalysis offers an attractive and 
often complementary alternative for the synthesis of enantiopure 
products.3 From a combinatorial perspective, the potential of 
directed evolution techniques in optimizing an enzyme’s selectivity 
is unrivaled.4 The present Communication outlines our efforts to 
create artificial metalloenzymes by incorporating an achiral rhodium-
diphosphine moiety into a protein environment to yield efficient 
enantioselective hydrogenation catalysts.
Inspired by the seminal work of E. T. Kaiser,5 several groups 
have recently developed methods to covalently modify proteins by 
incorporating transition-metal catalysts to yield hybrid catalytic 
systems with promising properties.4d,6,7
The approach delineated herein relies on noncovalent interactions 
between the metal catalyst and the protein. As no chemical coupling 
step is required upon addition of the catalyst precursor to the protein, 
the integrity of organometallic species is warranted.8 As proposed 
by Whitesides, the biotin-avidin system9 offers an attractive 
scaffold to perform such experiments.10
Initial enantioselective hydrogenation of acetamidoacrylic acid 
was performed with biotinylated amino-diphosphine ligands Biot-1 
and Biot-2 using avidin as the host protein (Scheme 1).11 The 
modest levels of enantioselection obtained with both ligand scaffolds 
(Table 1, entries 110a and 2) led us to question the affinity of the 
catalyst precursors [Rh(COD)(Biot-1)]+ and [Rh(COD)(Biot-2)]+ 
for avidin. Indeed, the Coulomb repulsion caused by the cationic 
character of avidin at neutral pH (pI ) 10.4) may dramatically 
decrease the affinity of the biotinylated cationic catalysts for avidin. 
We thus tested neutravidin (pI ) 6.3) with catalysts [Rh(COD)-
(Biot-1)]+ and [Rh(COD)(Biot-2)]+ (7% ee (S) and 10% ee (S), 
respectively, entries 3 and 4).
As compared to avidin, streptavidin (pI ) 6.2) possesses a similar 
affinity for biotin (Ka ca. 1014 M-1) but is endowed with a deeper 
binding pocket.12 In the spirit of E. Fischer’s lock-and-key principle, 
streptavidin may thus offer a more propitious environment for an 
enantiodiscrimination event. To our delight, catalyst precursor 
[Rh(COD)(Biot-1)]+ displayed good enantioselectivity, in favor of 
the (R)-enantiomer (92% ee, entry 5). The catalyst derived from 
[Rh(COD)(Biot-2)]+ performed sluggishly to afford acetamidoala-
nine in 20% ee (S) with only 55% conversion after 15 h (entry 6).
To optimize the enantioselectivity of the reduction, two comple-
mentary strategies can be pursued: chemical modification of the 
first coordination sphere of the biotinylated catalyst or genetic 
modification of the gene coding the protein. So far, our efforts have 
focused primarily on the introduction of an amino acid spacer 
between biotin and the aminodiphosphine. This allows one to probe 
the topography of the host protein’s binding pocket in search of a
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entry 11). For streptavidin, [Rh(COD)(Biot-4ortho-1)]+ catalyzes
the reduction of acetamidoacrylic acid to (R)-acetamidoalanine in
92% ee (entry 12). All other ligand-spacer-protein combinations
yielded acetamidoalanine with an ee < 40%.11
The catalytic experiments reported herein reveal several note-
worthy features:
(i) As the host protein, streptavidin is generally a better chiral
inducer than avidin. Good levels of enantioselection, that match or
exceed those obtained with catalysts devoid of spacers, can be
achieved with either a glycine 31 or a â-alanine 32 spacer for avidin
and an anthranilic acid 4ortho spacer in streptavidin. Although both
enantiomers can be obtained with both proteins, streptavidin
produces preferentially the (R)-enantiomer, and avidin produces
preferentially the (S)-enantiomer.
(ii) The flexible ligand skeleton 1 generally catalyzes the
reduction with a higher enantioselectivity than the more rigid ligand
skeleton 2.13 Along the lines of the quadrant rule,1b we suggest
that the conformation of the biotinylated chelating ligand (which
exists as a racemic mixture in solution, but may be biased in favor
of one enantiomer, ì or ä, upon incorporation in the host protein)
plays a determinant role in the enantioselection event.
(iii) Buffer-screening experiments reveal that the fastest reduction
rates and slightly higher enantioselectivities are obtained at neutral
pH for avidin (0.1 M MOPS, pH 7.0 or 0.07 M phosphate buffer,
pH 7.1) and acidic pH for streptavidin (0.1 M acetate buffer, pH
4.0 or 0.1 M MES, pH 6.0). This suggests that the Coulomb
repulsion between the biotinylated catalyst and the cationic protein
is not responsible for the modest performance with avidin as a host
protein.
(iv) To test the substrate specificity of these hybrid catalysts,
the reduction of acetamidocinnamic acid was carried out using
[Rh(COD)(Biot-1)]+streptavidin and [Rh(COD)(Biot-4ortho-
1)]+streptavidin to yield (R)-acetamidophenylalanine with 86%
ee (pH 6.0, MES buffer) and 83% ee (pH 6.0, MES buffer),
respectively (as compared to 92% for (R)-acetamidoalanine, Table
1, entries 5 and 12). The substrate tolerance displayed by these
hybrid catalysts is thus more typical of homogeneous than of
enzymatic catalysis.1e Because the host protein was by no means
designed to stabilize the transition state of a hydrogenation reaction,
it is more tolerant toward substrates of varying steric requirements.
(v) These artificial metalloenzymes are amenable to a chemo-
genetic optimization procedure. Having identified by chemical
modification the most promising organometallic fragments (entries
5 and 12), we subjected the streptavidin to site-directed mutagenesis.
Preliminary experiments were performed by substituting single
amino acids by a glycine4d in the flexible regions of streptavidin
close to the biotin-binding site. Substitution of serine 112 by a
glycine residue in the L7,8 loop of streptavidin (S112G) yields an
improved host protein for the reduction of acetamidoacrylic acid
both with [Rh(COD)(Biot-1)]+streptavidin S112G and with
[Rh(COD) (Biot-4ortho-1)]+streptavidin S112G (96% ee (R) and
94% ee (R), entries 13 and 14, respectively).
In the field of homogeneous catalysis, the steric and the electronic
control of a catalytic moiety is mostly limited to the first
coordination sphere of the metal. This contrasts with enzymes which
take advantage both of the first and of the second coordination
sphere to produce catalysts with exquisite activity and selectivity.
The artificial metalloenzymes presented herein offer an attractive
way to exploit the second coordination sphere provided by a host
protein to produce versatile enantioselective catalysts with features
reminiscent both of enzymatic and of organometallic catalysts. We
have demonstrated that the enantioselectivity may be optimized
either chemically or genetically (i.e., chemogenetic), thus offering
an ideal scaffold for high-throughput optimization of enantiose-
lective catalysts.
Finally, these hybrid enantioselective catalysts offer interesting
perspectives toward “greener” organometallic catalysis as they
operate in water and should prove easy to recycle either by
immobilization or by size-selective filtration.
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